SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 76 filers reported holding SERES THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.45 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -57.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +40.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -81.5% | 1,000 | -71.4% | 0.00% | – |
| Q3 2018 | $27,000 | +145.5% | 3,500 | +133.3% | 0.00% | – |
| Q2 2018 | $11,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | -57.7% | 1,500 | -42.3% | 0.00% | – |
| Q4 2017 | $26,000 | -23.5% | 2,600 | +23.8% | 0.00% | – |
| Q3 2017 | $34,000 | +61.9% | 2,100 | +10.5% | 0.00% | – |
| Q2 2017 | $21,000 | +110.0% | 1,900 | +111.1% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 900 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -18.2% | 900 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -8.3% | 900 | +125.0% | 0.00% | – |
| Q2 2016 | $12,000 | +50.0% | 400 | +33.3% | 0.00% | – |
| Q1 2016 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |